Nova Patents
IL219407B

Dimethyl sulfoxide (dmso) and methylsulfonylmethane (msm) formulations to treat osteoarthritis

Abstract

This record has no abstract on file.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Published
  4. Today

99 members in 16 offices

This recordMember, by publication datePriority claim6 more offices are in the list below

Priority claims3

Priority claims
DocumentOfficeKindDate
25693509United States of AmericaP
31920310United States of AmericaP
2010054870United States of AmericaW

Members99

Family members, oldest first
DocumentOfficeKind
CA2778142A1CanadaA1
CA2778144A1CanadaA1
CA2779111A1CanadaA1
US2011105623A1United States of AmericaA1
WO2011053848A1World Intellectual Property Organization (WIPO)A1
WO2011053854A1World Intellectual Property Organization (WIPO)A1
WO2011053874A1World Intellectual Property Organization (WIPO)A1
WO2011053875A1World Intellectual Property Organization (WIPO)A1
AU2010281739A1AustraliaA1
AU2010281739B2AustraliaB2
US2011136210A1United States of AmericaA1
US2011152231A1United States of AmericaA1
AU2011204961A1AustraliaA1
AU2010313253A1AustraliaA1
AU2010313228A1AustraliaA1
US2012149672A1United States of AmericaA1
IL219320A0IsraelA0
IL219320D0IsraelD0
IL219321A0IsraelA0
IL219321D0IsraelD0
IL219407A0IsraelA0
IL219407D0IsraelD0
US8217085B2United States of AmericaB2
MX2012005159AMexicoA
MX2012005014AMexicoA
US2012207827A1United States of AmericaA1
KR20120093993ARepublic of KoreaA
US2012220667A1United States of AmericaA1
EP2493314A1European Patent Office (EPO)A1
EP2493315A1European Patent Office (EPO)A1
EP2493464A1European Patent Office (EPO)A1
EP2494059A1European Patent Office (EPO)A1
KR20120107951ARepublic of KoreaA
CN102724973AChinaA
US2012264726A1United States of AmericaA1
CN102834520AChinaA
US2013045941A1United States of AmericaA1
JP2013509197AJapanA
JP2013509437AJapanA
JP2013509440AJapanA
US2013065967A9United States of AmericaA9
EP2493464A4European Patent Office (EPO)A4
EP2493314A4European Patent Office (EPO)A4
EP2493315A4European Patent Office (EPO)A4
US8546373B2United States of AmericaB2
EP2494059A4European Patent Office (EPO)A4
US2013338130A1United States of AmericaA1
NZ600145ANew ZealandA
AU2011204961B2AustraliaB2
KR20140015146ARepublic of KoreaA
AU2010313228B2AustraliaB2
CN102724973BChinaB
NZ600134ANew ZealandA
US8841100B2United States of AmericaB2
US2014349375A1United States of AmericaA1
JP5651186B2JapanB2
AU2010313253B2AustraliaB2
SG10201500283UASingaporeA
AU2015202432A1AustraliaA1
IL219320AIsraelA
CN102834520BChinaB
ZA201203054BSouth AfricaB
ZA201203083BSouth AfricaB
JP5947721B2JapanB2
US9487749B2United States of AmericaB2
EP2494059B1European Patent Office (EPO)B1
BR112012010270A2BrazilA2
AU2015202432B2AustraliaB2
DK2494059T3DenmarkT3
ES2616630T3SpainT3
IL219321AIsraelA
KR101763560B1Republic of KoreaB1
US9839609B2United States of AmericaB2
MX353059BMexicoB
US9855212B2United States of AmericaB2
MX353712BMexicoB
KR101826531B1Republic of KoreaB1
EP2493315B1European Patent Office (EPO)B1
US2018092838A1United States of AmericaA1
EP2493464B1European Patent Office (EPO)B1
CA2778142CCanadaC
DK2493464T3DenmarkT3
ES2674019T3SpainT3
EP2493464B8European Patent Office (EPO)B8
IL219407AIsraelA
IL219407BThis recordIsraelB
IL259683D0IsraelD0
US2018214373A1United States of AmericaA1
ZA201203907BSouth AfricaB
MX367373BMexicoB
CA2779111CCanadaC
BR112012010272A2BrazilA2
US10596109B2United States of AmericaB2
EP2493314B1European Patent Office (EPO)B1
CA2778144CCanadaC
IL259683AIsraelA
IL259683BIsraelB
US2020297625A1United States of AmericaA1
US2023240984A1United States of AmericaA1